These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6364848)

  • 21. Modification by prostaglandins E1 and E2, indomethacin, and arachidonic acid of the vasoconstrictor responses of the isolated perfused rabbit and rat mesenteric arteries to adrenergic stimuli.
    Malik KU; Ryan P; McGiff JC
    Circ Res; 1976 Aug; 39(2):163-8. PubMed ID: 181162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of prostaglandins on pancreatic circulation in anesthetized dogs.
    Homma T; Malik KU
    J Pharmacol Exp Ther; 1982 Sep; 222(3):623-8. PubMed ID: 7050343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of effects of prostaglandins E2 and I2 on rat renal vascular resistance.
    Baer PG; McGiff JC
    Eur J Pharmacol; 1979 Mar; 54(4):359-63. PubMed ID: 374096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandin I2 and prostaglandin E2 modulate human intrarenal artery contractility through prostaglandin E2-EP4, prostacyclin-IP, and thromboxane A2-TP receptors.
    Eskildsen MP; Hansen PB; Stubbe J; Toft A; Walter S; Marcussen N; Rasmussen LM; Vanhoutte PM; Jensen BL
    Hypertension; 2014 Sep; 64(3):551-6. PubMed ID: 24914192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of arotinolol on hemodynamics and adrenergically induced renin release and renal vasoconstriction.
    Suzuki-Kusaba M; Hisa H; Kimura T; Satoh S
    Arzneimittelforschung; 1988 May; 38(5):671-7. PubMed ID: 2458109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of prostaglandin E2, indomethacin, and reserpine on renal vascular responses to nerve stimulation, pressor and depressor hormones.
    Fink GD; Chapnick BM; Goldberg MR; Paustian PW; Kadowitz PJ
    Circ Res; 1977 Aug; 41(2):172-8. PubMed ID: 872290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hemodynamic effects of prostaglandins in the rat. Evidence for important species variation in renovascular responses.
    Gerber JG; Nies AS
    Circ Res; 1979 Mar; 44(3):406-10. PubMed ID: 367631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
    Pernow J; Lundberg JM
    Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attenuation by bradykinin of adrenergically-induced vasoconstriction in the isolated perfused kidney of the rabbit: relationship to prostaglandin synthesis.
    Malik KU; Nasjletti A
    Br J Pharmacol; 1979 Oct; 67(2):269-75. PubMed ID: 497530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal vasodilation with ureteral occlusion and prostaglandins: attenuation by histamine H1 antagonists.
    Banks RO; Jacobson ED
    Am J Physiol; 1985 Dec; 249(6 Pt 2):F851-7. PubMed ID: 2866716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandins and renal blood flow: in vivo studies.
    Lifschitz MD
    Kidney Int; 1981 Jun; 19(6):781-5. PubMed ID: 6790809
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of verapamil on renal vasoconstriction induced by angiotensin II, norepinephrine or renal nerve stimulation in anesthetized dogs.
    Ogawa N; Kushida H; Satoh S
    Arch Int Pharmacodyn Ther; 1984 Mar; 268(1):113-21. PubMed ID: 6732356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible mechanism of prostaglandin-induced renal vasoconstriction in the rat.
    Schor N; Brenner BM
    Hypertension; 1981; 3(6 Pt 2):II-81-5. PubMed ID: 7028624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defective modulation of noradrenergic neurotransmission by exogenous prostaglandins in aging spontaneously hypertensive rats.
    Jackson EK; Herzer WA; Lawson JA
    J Pharmacol Exp Ther; 1989 Dec; 251(3):858-69. PubMed ID: 2557420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of vasoconstrictor responses by prostacyclin (PGI2) in the feline mesenteric vascular bed.
    Lippton HL; Chapnick BM; Hyman AL; Kadowitz PJ
    Arch Int Pharmacodyn Ther; 1979 Oct; 241(2):214-23. PubMed ID: 393194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired ability of prostaglandins to buffer renal vasoconstriction in genetically hypertensive rats.
    Chatziantoniou C; Arendshorst WJ
    Am J Physiol; 1992 Oct; 263(4 Pt 2):F573-80. PubMed ID: 1329556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of renal nerve stimulation, norepinephrine and angiotensin II on renal blood flow in relation to release of PG-like substances in anesthetized dogs.
    Satoh S; Ohyama Y; Hayashi M
    Arch Int Pharmacodyn Ther; 1981 Dec; 254(2):304-16. PubMed ID: 7337502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of COX-2-derived metabolites in regulation of the renal hemodynamic response to norepinephrine.
    Llinás MT; López R; Rodríguez F; Roig F; Salazar FJ
    Am J Physiol Renal Physiol; 2001 Nov; 281(5):F975-82. PubMed ID: 11592955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiated vasoconstrictor response to vasopressin following meclofenamate in conscious rats.
    Walker BR; Brizzee BL; Harrison-Bernard LM
    Proc Soc Exp Biol Med; 1988 Feb; 187(2):157-64. PubMed ID: 3340625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for prostaglandin mediated prejunctional control of renal sympathetic transmitter release and vascular tone.
    Frame MH; Hedqvist P
    Br J Pharmacol; 1975 Jun; 54(2):189-96. PubMed ID: 238706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.